A couple of weeks ago we wrote of some promising presbyopia updates, including Allergan (an AbbVie company). Allergan have now announced the FDA approval of Vuity. This the first eyedrop for the treatment of presbyopia to have been approved by the FDA. It is a daily prescription eyedrop which can work in as quickly as 15 minutes and last up to 6 hours. "We are proud to offer Vuity as a first-of-its-kind once-daily eye drop that we believe will change the way people and their eye doctors approach presbyopia” Michael Severino, MD, vice chairman and president, AbbVie.
LENZ Therapeutics is working on eyedrops which will contain aceclidine, it is hoped aceclidine will create a pinhole effect as a miotic. It has shown improvements in their recent phase 2 trial.
Leave a Reply.
James Pickering is our Managing Director and an eye care recruitment expert who has developed an extensive client base and candidate network. He regularly writes articles about industry developments and has received numerous recommendations from industry leaders. You can also connect with James on LinkedIn to stay up to date on the latest eye care news.